Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Adjuvant radiation
RADIATION
2 trials
Sponsors
Zefen Xiao
, Fudan University
Conditions
Esophageal Cancer
Esophageal Neoplasms
Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Phase 1
Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC
Recruiting
NCT06494943
Fudan University
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Start: 2024-06-26
End: 2028-12-31
Target: 27
Updated: 2025-02-25
Phase 2
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
NCT02279134
Zefen Xiao
Esophageal Cancer, Esophageal Neoplasms
Start: 2014-10-31
End: 2024-12-31
Target: 360
Updated: 2020-04-03
Related Papers
Neoadjuvant IBI110 and sintilimab in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma.
Journal of Clinical Oncology
2025-05-28
Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A post hoc analysis of a randomized controlled trial
Frontiers in Oncology
2022-09-08
12 citations
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
2020-02-18
14 citations